Surgery for Metastatic Urothelial Carcinoma
Author Information
Author(s): Bhalla Sophia, Pfail John, Ghodoussipour Saum
Primary Institution: Rutgers Cancer Institute of New Jersey
Hypothesis
Can surgery improve survival in patients with metastatic urothelial carcinoma?
Conclusion
Surgery may improve survival in select patients with metastatic urothelial carcinoma, particularly those with good performance status and a single site of metastasis.
Supporting Evidence
- 15 of 17 studies showed improved survival with chemotherapy followed by radical cystectomy.
- 12 of 13 studies indicated improved survival with metastasectomy.
- Patient characteristics correlated with improved survival include good performance status and good response to chemotherapy.
Takeaway
This study looks at whether surgery can help people with advanced bladder cancer live longer. It found that some patients might benefit from surgery if they are in good shape and have only one area of cancer spread.
Methodology
A literature search was conducted for studies discussing surgery in patients with metastatic urothelial carcinoma, focusing on cytoreductive radical cystectomy and distant metastasectomy.
Potential Biases
The studies included varied in quality and design, which may introduce bias in the results.
Limitations
Most studies included were retrospective and lacked control groups, which may affect the reliability of the findings.
Participant Demographics
The studies included a range of patients with metastatic urothelial carcinoma, with varying characteristics such as performance status and response to chemotherapy.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI 14–55
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website